Eric Brochet

Showing 1-12 of 12 articles

Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis

Schlotter F, Miura M, Kresoja K, Alushi B, Alessandrini H, Attinger-Toller A, Besler C, Biasco L, Braun D, Brochet E, Connelly K, de Bruijn S, Denti P, Estevez-Loureiro R, Fam N, Gavazzoni M, Himbert D, Ho E, Juliard J, Kalbacher D, Kaple R, Kreidel F, Latib A, Lubos E, Ludwig S, Mehr M, Monivas V, Nazif T, Nickenig G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Rommel K, Schäfer U, Schofer J, Sievert H, Tang G, Thiele H, Unterhuber M, Vahanian A, von Bardeleben R, von Roeder M, Webb J, Weber M, Wild M, Windecker S, Zuber M, Hausleiter J, Maisano F, Leon M, Hahn R, Lauten A, Taramasso M, Lurz P

July 20, 2021 | 10.4244/EIJ-D-21-00191

Interventions for valvular disease

Predictors and clinical impact of thrombosis after transcatheter mitral valve implantation using balloon-expandable bioprostheses

Kikoïne J, Urena M, Chong Nguyen C, Fischer Q, Carrasco J, Brochet E, Ducrocq G, Vahanian A, Iung B, Himbert D

April 20, 2021 | 10.4244/EIJ-D-20-00991

Interventions for valvular disease

Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study

Nickenig G, Weber M, Schüler R, Hausleiter J, Näbauer M, von Bardeleben R, Sotiriou E, Schäfer U, Deuschl F, Alessandrini H, Kreidel F, Juliard J, Brochet E, Latib A, Montorfano M, Agricola E, Baldus S, Friedrichs K, Deo S, Gilmore S, Feldman T, Hahn R, Maisano F

February 5, 2021 | 10.4244/EIJ-D-20-01107

Atrial septal defect and ASO device: an unusual story

Aubry P, Juliard J, Brochet E

July 19, 2019 | 10.4244/EIJV15I4A56

Interventions for valvular disease

Alcohol septal ablation preceding transcatheter valve implantation to prevent left ventricular outflow tract obstruction

Sayah N, Urena M, Brochet E, Himbert D

April 20, 2018 | 10.4244/EIJ-D-17-00742

Transcatheter aortic valve implantation: transfemoral approach

Himbert D, Roy D, Brecker S, Brochet E, Depoix J-P, Radu C, Laborde J-C, Vahanian A

November 16, 2016

Interventions for valvular disease

Multiple valve disease - assessment, strategy and intervention

Vahanian A, Himbert D, Brochet E

September 17, 2015 | 10.4244/EIJV11SWA3

Transfemoral valve-in-ring implantation for a failing mitral homograft in the tricuspid position

Fassa A-A, Himbert D, Brochet E, Labbe J-P, Vahanian A

June 20, 2014 | 10.4244/EIJV10I2A43

Emergency transseptal transcatheter mitral valve-in-valve implantation

Fassa A-A, Himbert D, Brochet E, Alkhoder S, Al-Attar N, Brun P-Y, Wolff M, Nataf P, Vahanian A

September 27, 2013 | 10.4244/EIJV9I5A101

Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks

Calvert P, Himbert D, Brochet E, Radu C, Iung B, Hvass U, Darondel J-M, Depoix J-P, Nataf P, Vahanian A

March 21, 2012 | 10.4244/EIJV7I11A209

Tools & Techniques: Transcatheter aortic valve implantation: transfemoral approach

Himbert D, Roy D, Brecker S, Brochet E, Depoix J-P, Radu C, Laborde J-C, Vahanian A

January 20, 2011

Percutaneous Patent Foramen Ovale (PFO) closure in young patients with both cryptogenic brain infarction and PFO associated with Atrial Septal Aneurysm (ASA)

Juliard J, Abboud H, Aubry P, Brochet E, Sauguet A, Depoix J-P, Philip Y, Messika-Zeitoun D, Lung B, Vahanian A, Amarenco P

November 20, 2006

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.